
Myriad Genetics is a leading molecular and companion diagnostics company
Myriad is dedicated to making a difference in patients’ lives through the discovery and commercialization of transformative products that assess a person’s risk of developing disease, aid in a timely and accurate diagnosis, determine the risk of disease progression and recurrence and guide personalized treatment decisions.
Myriad is dedicated to saving lives and improving the quality of life of patients worldwide through the discovery and commercialization of novel, transformative diagnostic products and services across major diseases.